Drug Research

According to Stella Kyriakides, the EU Health Commissioner, the thought about changes to EU pharmaceutical law shall have robust obligations for medicine supply and also earlier shortage notifications. She was speaking at the European Parliament session, where she opined that...

The FDA's Final Guidance on REMS programmes for prescription medications, has just been published. The document is officially titled Format and Content of a REMS Document: Guidance for Industry. The FDA may demand a risk management strategy known as REMS,...

The US and Switzerland have agreed to a Mutual Recognition Agreement (MRA) on pharmaceutical Good Manufacturing Practices (GMP). The US Food and Drug Administration (FDA) and the Swiss Agency for Therapeutic Products (Swissmedic) will be able to utilize each other's...

The biotechnology sector had a decline in 2022 that went beyond just falling stock prices. Additionally, only 37 new drugs were approved by the FDA's primary review office last year, the lowest number since 2016. Yet there is cause for...

In the 70 pharmaceuticals featured in Clarivate Plc's Drugs to WatchTM 2023 study, comprising potential blockbuster drugs, the bulk were found to be personalised medicines. The report provides a predicted analysis of new medication launches or major indication launches in...

Metagenomics, the study of genetic material extracted directly from the stool microbiomes of people with PD and neurologically healthy control participants, was used by researchers at the University of Alabama at Birmingham in the US. The gut microbiome is engaged...

The AMR Action Fund, a public-private partnership investing in biotech companies developing antimicrobials, has invested in BioVersys AG, a clinical-stage company based in Basel, Switzerland. The transaction marks the Fund's first investment in Europe and is an important step...